Turtle Creek Wealth Advisors LLC Makes New $221,000 Investment in HCA Healthcare, Inc. $HCA

Turtle Creek Wealth Advisors LLC acquired a new position in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 578 shares of the company’s stock, valued at approximately $221,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Cheviot Value Management LLC bought a new position in HCA Healthcare during the first quarter worth $26,000. Saudi Central Bank bought a new stake in shares of HCA Healthcare in the first quarter valued at about $26,000. WPG Advisers LLC bought a new stake in shares of HCA Healthcare in the first quarter valued at about $27,000. Ameriflex Group Inc. bought a new stake in shares of HCA Healthcare in the second quarter valued at about $27,000. Finally, Chung Wu Investment Group LLC bought a new stake in shares of HCA Healthcare in the second quarter valued at about $27,000. 62.73% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, EVP Michael S. Cuffe sold 3,836 shares of the company’s stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the sale, the executive vice president directly owned 31,503 shares in the company, valued at $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 1.30% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on HCA shares. Wells Fargo & Company boosted their price target on HCA Healthcare from $375.00 to $412.00 and gave the company an “equal weight” rating in a research note on Tuesday, October 7th. Mizuho boosted their price target on HCA Healthcare from $425.00 to $475.00 and gave the company an “outperform” rating in a research note on Friday. The Goldman Sachs Group started coverage on HCA Healthcare in a research note on Tuesday. They issued a “buy” rating and a $470.00 price target for the company. Truist Financial set a $460.00 price target on HCA Healthcare in a research note on Tuesday. Finally, KeyCorp boosted their target price on HCA Healthcare from $370.00 to $465.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $434.00.

Get Our Latest Report on HCA

HCA Healthcare Price Performance

HCA Healthcare stock opened at $425.50 on Friday. The business has a 50 day moving average of $410.05 and a 200-day moving average of $378.21. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $439.01. The company has a market capitalization of $99.56 billion, a P/E ratio of 17.89, a P/E/G ratio of 1.33 and a beta of 1.40.

HCA Healthcare (NYSE:HCAGet Free Report) last released its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. During the same quarter in the prior year, the firm posted $5.50 earnings per share. The firm’s revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th were issued a $0.72 dividend. The ex-dividend date was Tuesday, September 16th. This represents a $2.88 annualized dividend and a yield of 0.7%. HCA Healthcare’s dividend payout ratio is presently 12.11%.

HCA Healthcare Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Stories

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.